Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets

American Journal of Transplantation

Volumn 7, Issue 11, 2007, Pages 2455-2462

  Hernandez Fisac I ^a   Pizarro Delgado, J ^a   Calle, C ^a   Marques, M ^b   Sanchez A ^b   Barrientos, A ^b   Tamarit Rodriguez, J ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Insulin genes; Pancreatic islets; Post transplant diabetes; Tacrolimus

Indexed keywords

DNA; GLUCOSE; INSULIN; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA CONTENT; DRUG WITHDRAWAL; GENE INACTIVATION; GENETIC TRANSCRIPTION; GLUCOSE INTOLERANCE; HORMONE INHIBITION; HYPERGLYCEMIA; INSULIN RELEASE; MALE; NONHUMAN; ORGAN WEIGHT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; TREATMENT WITHDRAWAL;

EID: 35248896198     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01946.x     Document Type: Article

References (30)

1. Grim M, Rinaldi M, Yonan NA et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients - A large European trial. Am J Transplant 2006 6 : 1387 1397.
2. Alessiani M, Cillo JJ, Fung W et al. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 1993 25 : 628 634.
3. Backman LA. Post-transplant diabetes mellitus: The last 10 years with tacrolimus. Nephrol Dial Transplant 2004 19 (Suppl. 6 vi13 vi16.
4. Hirano Y, Fujihira S, Ohara K, Katsuki S, Noguchi H. Morphological and functional changes of islets of Langerhans in FK506-treated rats. Transplantation 1992 53 : 889 894.
5. Hirano Y, Mitamura T, Tamura T, Ohara K, Mine Y, Noguchi H. Mechanism of FK506-induced glucose intolerance in rats. J Toxicol Sci 1994 19 : 61 65.
6. Strasser S, Alejandro R, Shapiro ET, Ricordi C, Todo S, Mintz DH. Effect of FK506 on insulin secretion in normal dogs. Metab Clin Exp 1992 41 : 94 67.
7. Ericzon B-G, Wijnen RMH, Kubota K, Kootstra G, Groth C-G. FK506-induced impairment of glucose metabolism in the primate. Studies in pancreatic transplant recipients and in nontransplanted animals. Transplantation 1992 54 : 615 620.
8. Ericzon B-G, Wijnen RMH, Tiebosch A, Kubota K, Kootstra G, Groth C-G. The effect of FK506 treatment on pancreatic duodenal allotransplantation in the primate. Transplantation 1992 53 : 1184 1189.
9. Tamura K, Fujimura T, Tsutsumi T et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic β-cell. Transplantation 1995 59 : 1606 1613.
10. Larsen JL, Bennett RG, Burkman T et al. Tacrolimus and sirolimus cause insulin resistance in normal Sprague Dawley rats. Transplantation 2006 82 : 466 470.
11. Herold KC, Nagamatsu S, Buse JB, Kulsakdinum P, Steiner DF. Inhibition of glucose-stimulated insulin release from BTC3 cells and rodent islets by an analog of FK506. Transplantation 1993 55 : 186 192.
12. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson MP. Effects of tacrolimus on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996 98 : 2786 2793.
13. Paty BW, Harmon JS, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 2002 73 : 353 357.
14. Uchizono Y, Iwase M, Nakamura U, Sasaki N, Goto D, Iida M. Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling. Endocrinology 2004 145 : 2264 2272.
15. Polastri L, Galbiati F, Bertuzzi F et al. Secretory defects induced by immunosuppressive agents on human pancreatic β-cells. Acta Diabetol 2002 39 : 229 233.
16. Oetjen E, Baun D, Beimesche S et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporine A and tacrolimus in primary, mature islets of transgenic mice. Mol Pharmacol 2003 63 : 1289 1295.
17. Sieman G, Blume R, Grapentin D, Oetjen E, Schwaninger M, Knepel W. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporine A and FK506 depends on the promoter context. Mol Pharmacol 1999 55 : 1094 1100.
18. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967 16 : 35 39.
19. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962 194 : 495 496.
20. Vytasek R. A sensitive fluorometric assay for the determination of DNA. Anal Biochem 1982 120 : 243 248.
21. Crissman HA, Steinkamp JA. Rapid, simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations. J Cell Biol 1973 59 : 766 771.
22. Ueki M, Yasunami Y, Ina K et al. Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat. Diabetes Res Clin Prac 1993 20 : 11 19.
23. López-Talavera JC, García-Ocaña A, Sipula I, Takane KK, Cozar-Castellano I, Stewart AF. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: Reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein transplantation. Endocrinology 2004 145 : 467 474.
24. Paty BW, Harmon S, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 2002 73 : 353 357.
25. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson RP. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 1996 98 : 2786 2793.
26. Heit JH, Apelqvist AA, Gu X et al. Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function. Nature 2006 443 : 345 349.
27. Lawrence MC, McGlynn K, Park B-H, Cobb MH. ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem 2005 280 : 26751 26759.
28. 2+-dependent dephosphorylation of kinesin heavy chain on β-granules in pancreatic β-cells. Implications for regulated β-granule transport and insulin exocytosis. J Biol Chem 2002 277 : 24232 24242.
29. Radu RG, Fujimoto S, Mukai E et al. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity. Am J Physiol Endocrinol Metab 2004 288 : E365 E371.
30. Drachenberg CB, Klassen DK, Weir MR et al. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999 68 : 396 402.